Abstract
In the armamentarium of calcium channel blockers appropriately functionalized 3,4-dihydropyrimidin-2(1H)- ones have received considerable attention in recent past owing to their structural similarity with 1,4-dihydropyridine based drugs. In this review, we highlight detailed investigations in the calcium channel blocking and other activities of this category of compounds as well as trace their genesis from 1,4-dihydropyridine based drugs.
Keywords: Dihydropyridines, dihydropyrimidines, dihydropyrimidinones, calcium channel blockers, mitotic kinesin inhibitors, α-adrenergic receptor antagonists, structure- activity relationships
Mini-Reviews in Medicinal Chemistry
Title:Genesis of Dihydropyrimidinone Calcium Channel Blockers: Recent Progress in Structure-Activity Relationships and Other Effects
Volume: 9 Issue: 1
Author(s): K. Singh, D. Arora and S. Singh
Affiliation:
Keywords: Dihydropyridines, dihydropyrimidines, dihydropyrimidinones, calcium channel blockers, mitotic kinesin inhibitors, α-adrenergic receptor antagonists, structure- activity relationships
Abstract: In the armamentarium of calcium channel blockers appropriately functionalized 3,4-dihydropyrimidin-2(1H)- ones have received considerable attention in recent past owing to their structural similarity with 1,4-dihydropyridine based drugs. In this review, we highlight detailed investigations in the calcium channel blocking and other activities of this category of compounds as well as trace their genesis from 1,4-dihydropyridine based drugs.
Export Options
About this article
Cite this article as:
K. Singh, D. Arora and S. Singh , Genesis of Dihydropyrimidinone Calcium Channel Blockers: Recent Progress in Structure-Activity Relationships and Other Effects, Mini-Reviews in Medicinal Chemistry 2009; 9 (1) . https://dx.doi.org/10.2174/138955709787001686
DOI https://dx.doi.org/10.2174/138955709787001686 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Eluting Coronary Artery Stents
Current Drug Delivery Biochemical, Hematological and Histopathological Indices of Wistar Rats Fed Vitamin and Mineral Deficient Diets Supplemented with Moringa oleifera Leaf Meal
Current Nutrition & Food Science Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry Pharmacokinetics and Biotransformation of Tea Polyphenols
Current Drug Metabolism Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery A Systematic Approach to Hypertensive Urgencies and Emergencies
Current Hypertension Reviews Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology Calcium Handling and Arrhythmogenesis
Medicinal Chemistry Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics Molecular Modeling Investigation of Folic Acid Conjugation to MDM2 Inhibitors for Enhanced Cellular Uptake and Target Binding
Current Computer-Aided Drug Design Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design ErbB4 and its Isoforms: Patentable Drug Targets?
Recent Patents on DNA & Gene Sequences Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Drug Eluting Stents and Beyond
Current Pharmaceutical Design Opportunities for Pharmacotherapy at the Intersection of Metabolic Syndrome and Hemostasis
Current Pharmaceutical Biotechnology A New Battlefield Towards Global Health in 21<sup>st</sup> Century: Clinical Research Networks
Applied Clinical Research, Clinical Trials and Regulatory Affairs